Feasibility & Implementation of a Plant-Based Weight-Loss Program in an Office-Based Setting

Blood Pressure Clinical Trial

Official title: The Feasibility, Implementation and Efficacy of a Plant-Based Weight-Loss Program in a Practice-Based Setting

Status Active, not recruiting

Clinical Trial Summary

This prospective study aims to assess the feasibility and implementation of a plant-based, weight-loss program in an office setting. The study will also assess changes in body weight, blood pressure, plasma lipids, glycated hemoglobin, and body composition with a 12-week, plant-based, weight-loss program. These health benefits may illustrate feasibility to physicians and healthcare professionals elsewhere.

Clinical Trial Description

This will be a prospective interventional study to evaluate the feasibility, implementation and efficacy of 12-week plant-based, weight-loss program that is carried out in an office setting and is open to participation to the general public via local print and online advertising or whichever methods apply. The program will include weekly education and support, and assessment of blood pressure, lipids, hemoglobin A1c, and body composition before and after starting the program. The price of the program, $645, will cover the costs of weekly education, blood pressure check, laboratory testing and body composition analysis. ;

Related Conditions & MeSH terms

• Blood Pressure
• Body Weight
• Diabete Mellitus
• Diabetes Mellitus
• Lipid Disorder
• Lipid Metabolism Disorders
• PreDiabetes
• Weight Loss

• NCT number: NCT04091516
• Study type: Interventional
• Source: Physicians Committee for Responsible Medicine
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 30, 2019
• Completion date: December 31, 2025